ReviewExperimental hematology & oncology2017

Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia.

Guoqing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.